The global left atrial appendage closure devices market is expected to grow from USD 1.2 billion in 2018 to USD 2.5 billion by 2030, at a CAGR of 12.6% during the forecast period. The growth of this market can be attributed to the increasing prevalence of atrial fibrillation and its associated risk factors such as hypertension, diabetes mellitus, and obesity among others.
Epicardial LAA closure devices segment is expected to dominate the global left atrial appendage closure devices market during the forecast period owing to their ease of implantation and lower cost as compared with endocardial LAA closure devices. The application segment for heart clinics is expected to grow significantly during the forecast period owing to increasing number of patients suffering from chronic heart diseases such as hypertension, diabetes mellitus, and obesity among others which are leading causes for developing atrial fibrillation or irregular heartbeat condition that requires surgical intervention in order to prevent stroke or other complications arising out of it.
- The increasing prevalence of atrial fibrillation and the associated risk of stroke are driving the growth of the LAA closure devices market.
- The increasing number of patients with atrial fibrillation is also driving the growth of this market.
- Increasing awareness about LAA closure devices among physicians and patients is also contributing to its growth.
- Increasing adoption rates for these devices in developed countries such as North America, Europe, and Japan.
Industry Growth Insights published a new data on “Left Atrial Appendage (LAA) Closure Devices Market”. The research report is titled “Left Atrial Appendage (LAA) Closure Devices Market research by Types (Epicardial LAA Closure Devices, Endocardial LAA Closure Devices), By Applications (Heart Clinics, Hospitals, Ambulatory Service Centers), By Players/Companies AtriCure, Boston Scientific Corporation, Coherex Medical, St. Jude Medical, Occlutech, Lifetech Scientific, SentreHEART, Avantis Medical Systems, United-Guardian, Carestream Health”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Left Atrial Appendage (LAA) Closure Devices Market Research Report
By Type
Epicardial LAA Closure Devices, Endocardial LAA Closure Devices
By Application
Heart Clinics, Hospitals, Ambulatory Service Centers
By Companies
AtriCure, Boston Scientific Corporation, Coherex Medical, St. Jude Medical, Occlutech, Lifetech Scientific, SentreHEART, Avantis Medical Systems, United-Guardian, Carestream Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
 Closure Devices Industry Outlook.svg)
Global Left Atrial Appendage (LAA) Closure Devices Market Report Segments:
The global Left Atrial Appendage (LAA) Closure Devices market is segmented on the basis of:
Types
Epicardial LAA Closure Devices, Endocardial LAA Closure Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart Clinics, Hospitals, Ambulatory Service Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AtriCure
- Boston Scientific Corporation
- Coherex Medical
- St. Jude Medical
- Occlutech
- Lifetech Scientific
- SentreHEART
- Avantis Medical Systems
- United-Guardian
- Carestream Health
 Closure Devices Market Overview.svg)
Highlights of The Left Atrial Appendage (LAA) Closure Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Epicardial LAA Closure Devices
- Endocardial LAA Closure Devices
- By Application:
- Heart Clinics
- Hospitals
- Ambulatory Service Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Left Atrial Appendage (LAA) Closure Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Closure Devices Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Left atrial appendage (LAA) closure devices are medical devices that are inserted into the left atrium to close off the opening between the left atrium and ventricle. This can reduce or eliminate symptoms of heart failure, such as shortness of breath, fatigue, and chest pain.
Some of the major players in the left atrial appendage (laa) closure devices market are AtriCure, Boston Scientific Corporation, Coherex Medical, St. Jude Medical, Occlutech, Lifetech Scientific, SentreHEART, Avantis Medical Systems, United-Guardian, Carestream Health.
The left atrial appendage (laa) closure devices market is expected to grow at a compound annual growth rate of 12.6%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Left Atrial Appendage (LAA) Closure Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Left Atrial Appendage (LAA) Closure Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Left Atrial Appendage (LAA) Closure Devices Market - Supply Chain
4.5. Global Left Atrial Appendage (LAA) Closure Devices Market Forecast
4.5.1. Left Atrial Appendage (LAA) Closure Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Left Atrial Appendage (LAA) Closure Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Left Atrial Appendage (LAA) Closure Devices Market Absolute $ Opportunity
5. Global Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Type
5.3.1. Epicardial LAA Closure Devices
5.3.2. Endocardial LAA Closure Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Application
6.3.1. Heart Clinics
6.3.2. Hospitals
6.3.3. Ambulatory Service Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Left Atrial Appendage (LAA) Closure Devices Demand Share Forecast, 2019-2026
9. North America Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Application
9.4.1. Heart Clinics
9.4.2. Hospitals
9.4.3. Ambulatory Service Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Type
9.7.1. Epicardial LAA Closure Devices
9.7.2. Endocardial LAA Closure Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Left Atrial Appendage (LAA) Closure Devices Demand Share Forecast, 2019-2026
10. Latin America Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Application
10.4.1. Heart Clinics
10.4.2. Hospitals
10.4.3. Ambulatory Service Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Type
10.7.1. Epicardial LAA Closure Devices
10.7.2. Endocardial LAA Closure Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Left Atrial Appendage (LAA) Closure Devices Demand Share Forecast, 2019-2026
11. Europe Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Application
11.4.1. Heart Clinics
11.4.2. Hospitals
11.4.3. Ambulatory Service Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Type
11.7.1. Epicardial LAA Closure Devices
11.7.2. Endocardial LAA Closure Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Left Atrial Appendage (LAA) Closure Devices Demand Share, 2019-2026
12. Asia Pacific Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Application
12.4.1. Heart Clinics
12.4.2. Hospitals
12.4.3. Ambulatory Service Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Type
12.7.1. Epicardial LAA Closure Devices
12.7.2. Endocardial LAA Closure Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Left Atrial Appendage (LAA) Closure Devices Demand Share, 2019-2026
13. Middle East & Africa Left Atrial Appendage (LAA) Closure Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Application
13.4.1. Heart Clinics
13.4.2. Hospitals
13.4.3. Ambulatory Service Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Left Atrial Appendage (LAA) Closure Devices Market Size and Volume Forecast by Type
13.7.1. Epicardial LAA Closure Devices
13.7.2. Endocardial LAA Closure Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Left Atrial Appendage (LAA) Closure Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Left Atrial Appendage (LAA) Closure Devices Market: Market Share Analysis
14.2. Left Atrial Appendage (LAA) Closure Devices Distributors and Customers
14.3. Left Atrial Appendage (LAA) Closure Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AtriCure
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Coherex Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. St. Jude Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Occlutech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lifetech Scientific
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SentreHEART
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Avantis Medical Systems
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. United-Guardian
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Carestream Health
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
